These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12973402)

  • 1. Monoclonal antibodies in the treatment of lymphoid leukemia.
    O'Brien S; Giles FJ
    Drugs Today (Barc); 2003 Jul; 39(7):541-50. PubMed ID: 12973402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies in the treatment of leukemia.
    O'Brien S; Albitar M; Giles FJ
    Curr Mol Med; 2005 Nov; 5(7):663-75. PubMed ID: 16305492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody therapy of leukaemias and lymphomas.
    Jacobs SA; Foon KA
    Expert Opin Biol Ther; 2005 Sep; 5(9):1225-43. PubMed ID: 16120052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies in the treatment of cancer, Part 1.
    Cersosimo RJ
    Am J Health Syst Pharm; 2003 Aug; 60(15):1531-48. PubMed ID: 12951753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody therapy.
    O'Mahony D; Bishop MR
    Front Biosci; 2006 May; 11():1620-35. PubMed ID: 16368542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic monoclonal antibodies in onco-hematology].
    Cartron G; Rossi JF
    Med Sci (Paris); 2009 Dec; 25(12):1085-9. PubMed ID: 20035683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody therapy in lymphoid malignancies.
    Hainsworth JD
    Oncologist; 2000; 5(5):376-84. PubMed ID: 11040273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New research and treatment options for acute myeloid leukemia.
    Miller CB
    Am J Manag Care; 2000 Oct; 6(18 Suppl):S973-4. PubMed ID: 11184567
    [No Abstract]   [Full Text] [Related]  

  • 9. A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL).
    Nabhan C; Patton D; Gordon LI; Riley MB; Kuzel T; Tallman MS; Rosen ST
    Leuk Lymphoma; 2004 Nov; 45(11):2269-73. PubMed ID: 15512816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic monoclonal antibodies].
    Geissler M; Blum HE
    Dtsch Med Wochenschr; 2000 Dec; 125(49):1501-4. PubMed ID: 11149212
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibodies in the treatment of cancer, Part 2.
    Cersosimo RJ
    Am J Health Syst Pharm; 2003 Aug; 60(16):1631-41; quiz 1642-3. PubMed ID: 12966906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia.
    Kharfan-Dabaja MA; Fahed R; Hussein M; Santos ES
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1799-815. PubMed ID: 17970639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the way.
    Tam CS
    Leuk Lymphoma; 2009 Oct; 50(10):1557-8. PubMed ID: 19757304
    [No Abstract]   [Full Text] [Related]  

  • 14. Alemtuzumab.
    Am J Health Syst Pharm; 2001 Dec; 58(24):2372-3. PubMed ID: 11794950
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid elimination of circulating leukemia cells with a small dose of alemtuzumab in refractory aggressive NK-cell leukemia.
    Sasaki M; Sugimoto K; Kawahara S; Yasuda H; Suto H; Oshimi K
    Eur J Haematol; 2007 Jun; 78(6):545. PubMed ID: 17419749
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia.
    Rosenblum MD; LaBelle JL; Chang CC; Margolis DA; Schauer DW; Vesole DH
    Blood; 2004 Mar; 103(5):1969-71. PubMed ID: 14976065
    [No Abstract]   [Full Text] [Related]  

  • 17. Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment.
    Fietz T; Rieger K; Schmittel A; Thiel E; Knauf W
    Hematol J; 2004; 5(5):451-2. PubMed ID: 15448675
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal antibodies in the treatment of chronic lymphocytic leukemia.
    Liu NS; O'Brien S
    Med Oncol; 2004; 21(4):297-304. PubMed ID: 15579912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antibody therapy in lymphoid malignancies.
    Dearden CE
    Br Med Bull; 2007; 83():275-90. PubMed ID: 17942451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond rituximab: The future of monoclonal antibodies in B-cell non-Hodgkin lymphoma.
    Sikder MA; Friedberg JW
    Curr Hematol Malig Rep; 2008 Oct; 3(4):187-93. PubMed ID: 20425465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.